Skip to main content

Table 4 Utility weights per health state

From: Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia

Health state

Derivation

Utility weight

Baseline

Based on average utilities of patients at baseline

0.848

Response

Value at Week 12

0.887

No response

Value at Week 12

0.870

Second-line treatment

Average of response and no response health states

0.879

Withdrawal

Assumed to be equal to the baseline utility

0.848

Discontinuation

Assumed to be equal to the baseline utility

0.848

Post-surgery

Derived by combining response utility value from NEPTUNE study with disutilities from [23], weighted by probability of improvement, no improvement and adverse events after surgery [23]

0.839

Death

Lowest utility possible

0.000